Poxviral-based vaccine elicits immunologic responses in prostate cancer patients

Ravi A Madan1, Christopher R Heery2, James L Gulley1

  • 1Laboratory of Tumor Immunology and Biology; National Cancer Institute; National Institutes of Health; Bethesda, MD USA ; Genitourinary Malignancies Branch; National Cancer Institute; National Institutes of Health; Bethesda, MD USA.

Oncoimmunology
|August 7, 2014
PubMed

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccinations01:51

Vaccinations

Overview
43.8K